WHO Pharmaceuticals Newsletter 1999, No. 03&04
(1999; 16 pages)
Table of Contents
Open this folder and view contentsRegulatory actions
Close this folderDrug surveillance
View the documentACE inhibitors: survey of renal monitoring: UK
View the documentAcenocoumarol: alopecia: Spain
View the documentAnti-thyroid drugs: agranulocytosis: UK
View the documentCannabis: two clinical trials to start soon: UK
View the documentClozapine: gastrointestinal obstruction: UK
View the documentDonepezil: review of adverse reactions: seizure and heart block: UK
View the documentDrugs and children: ADR reporting: new rules for paediatric trials of medicines: unlicensed drug use in neonates: UK
View the documentErgotamine: interaction with HIV protease inhibitors: France, Switzerland
View the documentFexofenadine: cardiac reaction: Netherlands
View the documentInhaled corticosteroids: peri-oral dermatitis: Israel
View the documentMirtazepine: intrahepatic cholestasis: Finland
View the documentNicorandil: mouth ulcers: France
View the documentOrlistat: caution against nonprescription use: UK
View the documentSildenafil: interaction with HIV protease inhibitors: UK
View the documentSucralfate: bezoar formation: UK
View the documentTopiramate: transient hemiparesis: UK
Open this folder and view contentsNew developments
Open this folder and view contentsMedical devices
Open this folder and view contentsMedication errors
Open this folder and view contentsVeterinary medicine
 

Inhaled corticosteroids: peri-oral dermatitis: Israel

Israel. Dermatologists have reported two cases of peri-oral dermatitis associated with the use of corticosteroid inhalers. Both patients were adult women who had used steroid inhalers: beclometasone for asthma or budesonide for vasomotor rhinitis: for several years. The peri-oral rash was itchy, erythematous and characterized by numerous small papules and pustules. It was effectively treated with oral erythromycin and topical tretinoin gel on one occasion and by oral erythromycin alone on two occasions. One patient now receives steroids by monthly intramuscular injection.

Topical steroids have previously been associated with cutaneous adverse reactions and peri-oral dermatitis has been reported in asthmatic children who use steroid inhalers. However, topical steroids are also listed among possible treatments for peri-oral dermatitis.

References:

1) The Pharmaceutical Journal Vol. 262, p. 213, 13 February 1999.

2) Shiri J & Amichai B. Perioral dermatitis induced by inhaled corticosteroids. Journal of Dermatological Treatment 9:259-260 (1998).

to previous section to next section
 

Last updated: May 3, 2013